Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-33675-1
PubMed Identifier: 36253349
Publication URI: http://europepmc.org/abstract/MED/36253349
Type: Journal Article/Review
Volume: 13
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723